Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

CAFÉ BLÅGÅRDS APOTEK ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 5.5% 5.5%   Bankruptcy risk   6.0% 6.6% 9.2% 9.2% 8.9% 3.1% 14.4% 14.4%   Credit score (0-100)   40 37 27 25 27 55 15 15   Credit rating   BBB BBB BB BB BB BBB BB BB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   1,879 1,829 1,734 1,820 1,838 2,404 0.0 0.0   EBITDA   164 50.6 14.8 47.5 -216 473 0.0 0.0   EBIT   135 48.7 14.8 47.5 -224 460 0.0 0.0   Pre-tax profit (PTP)   123.2 49.1 12.2 38.6 -227.2 411.1 0.0 0.0   Net earnings   123.2 49.1 12.2 38.6 -227.2 407.4 0.0 0.0   Pre-tax profit without non-rec. items   123 49.1 12.2 38.6 -227 411 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   1.9 0.0 0.0 0.0 30.4 114 0.0 0.0   Shareholders equity total   211 260 273 311 84.1 491 366 366   Interest-bearing liabilities   0.0 0.0 0.0 0.0 196 0.0 0.0 0.0   Balance sheet total (assets)   739 734 1,253 1,517 956 1,300 366 366   Net Debt   -372 -513 -1,105 -1,345 -476 -892 -366 -366     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   1,879 1,829 1,734 1,820 1,838 2,404 0.0 0.0   Gross profit growth   2.9% -2.7% -5.2% 5.0% 1.0% 30.8% -100.0% 0.0%   Employees   4 4 4 5 5 5 0 0   Employee growth %   -20.0% 0.0% 0.0% 25.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   739 734 1,253 1,517 956 1,300 366 366   Balance sheet change%   -5.3% -0.6% 70.7% 21.1% -37.0% 36.0% -71.8% 0.0%   Added value   164.5 50.6 14.8 47.5 -223.8 472.8 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -58 -4 0 0 23 71 -114 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   1.0 2.0 3.0 4.0 -1.0 1.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   7.2% 2.7% 0.9% 2.6% -12.2% 19.1% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   18.1% 7.0% 1.8% 3.7% -17.7% 41.2% 0.0% 0.0%   ROI %   91.8% 21.8% 6.7% 17.5% -74.2% 119.8% 0.0% 0.0%   ROE %   82.3% 20.8% 4.6% 13.2% -114.9% 141.6% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   28.7% 35.6% 21.8% 20.5% 8.8% 37.8% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -226.3% -1,013.6% -7,455.9% -2,834.7% 220.4% -188.6% 0.0% 0.0%   Gearing %   0.0% 0.0% 0.0% 0.0% 233.0% 0.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 0.0% 0.0% 0.0% 7.9% 54.4% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   1.3 1.3 1.2 1.2 1.2 1.4 0.0 0.0   Current Ratio   1.4 1.5 1.3 1.3 1.3 1.5 0.0 0.0   Cash and cash equivalent   372.2 513.1 1,105.0 1,345.3 672.3 891.7 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   209.3 260.4 272.6 311.2 205.1 381.0 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   41 13 4 9 -45 95 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   41 13 4 9 -43 95 0 0   EBIT / employee   34 12 4 9 -45 92 0 0   Net earnings / employee   31 12 3 8 -45 81 0 0